Mosessian Named one of Top 25 Women Chief Scientific Officers in 2025
Sherly Mosessian, PhD, SOFIE’s Chief Scientific Officer, has been recognized by the […]
Focus on FAPI Newsletter – Fall 2025
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
![[68Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial](https://sofie.com/wp-content/uploads/2025/09/image.png)
[68Ga]Ga-API-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial
Kim M Pabst, Manuel M Weber, Christina Laschinsky, Patrick Sandach, Timo Bartel, Alina T Küper, […]
90 Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors
Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, Mélanie Desaulniers, Kim Magaly Pabst, Ilektra Antonia Mavroeidi, […]
Early image acquisition 68Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma
D Ufton, J Heilinger, H Weis, T Fischer, K Schomäcker, C Bruns, G Dieplinger, H […]
FAPI Symposium at SNMMI Hits its Mark
June 22, 2025 – SOFIE’s fourth FAPI symposium at SNMMI was standing room only, reflecting […]
Focus on FAPI Newsletter – Spring 2025
A WORD FROM OUR CHIEF SCIENTIFIC OFFICER
Efficacy of [68Ga]Ga-FAPI-PET as a non-invasive evaluation method of liver fibrosis
Yuriko Mori, Katharina Tamburini, Emil Novruzov, Dominik Schmitt, Eleni Mavriopoulou, Sven H Loosen, Christoph Roderburg, […]
![Comparison of [99mTc]Tc-FAPI SPECT/CT and [18F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer](https://sofie.com/wp-content/uploads/2025/06/info.ibamolecular.jpg)
Comparison of [99mTc]Tc-FAPI SPECT/CT and [18F]FDG PET/CT as predictive biomarkers for immunotherapy response in gastrointestinal cancer
Yu Zhang, Hong Chen, Dajia Lin, Zhiyi Lin, Jiyun Shi, Hannan Gao, Chenshen Huang, Fangqing […]